147 related articles for article (PubMed ID: 12845666)
1. EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer.
Takahashi S; Urano T; Tsuchiya F; Fujimura T; Kitamura T; Ouchi Y; Muramatsu M; Inoue S
Int J Cancer; 2003 Sep; 106(3):310-5. PubMed ID: 12845666
[TBL] [Abstract][Full Text] [Related]
2. Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifen.
Ijichi N; Shigekawa T; Ikeda K; Miyazaki T; Horie-Inoue K; Shimizu C; Saji S; Aogi K; Tsuda H; Osaki A; Saeki T; Inoue S
Clin Breast Cancer; 2013 Dec; 13(6):465-70. PubMed ID: 24119785
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen.
Tsuchiya F; Ikeda K; Tsutsumi O; Hiroi H; Momoeda M; Taketani Y; Muramatsu M; Inoue S
Biochem Biophys Res Commun; 2001 Jun; 284(1):2-10. PubMed ID: 11374862
[TBL] [Abstract][Full Text] [Related]
4. A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer.
Tsuneizumi M; Nagai H; Harada H; Kazui T; Emi M
Ann Hum Biol; 2002; 29(4):457-60. PubMed ID: 12160478
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor-binding fragment-associated gene 9 expression and its clinical significance in human testicular cancer.
Fujimura T; Takahashi S; Urano T; Xiaoqiang L; Ogushi T; Muramatsu M; Ouchi Y; Kitamura T; Homma Y; Inoue S
Int J Urol; 2009 Mar; 16(3):329-32. PubMed ID: 19207611
[TBL] [Abstract][Full Text] [Related]
6. EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.
Suzuki T; Inoue S; Kawabata W; Akahira J; Moriya T; Tsuchiya F; Ogawa S; Muramatsu M; Sasano H
Br J Cancer; 2001 Nov; 85(11):1731-7. PubMed ID: 11742495
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.
Ogushi T; Takahashi S; Takeuchi T; Urano T; Horie-Inoue K; Kumagai J; Kitamura T; Ouchi Y; Muramatsu M; Inoue S
Cancer Res; 2005 May; 65(9):3700-6. PubMed ID: 15867365
[TBL] [Abstract][Full Text] [Related]
9. RCAS1 is associated with ductal breast cancer progression.
Rousseau J; Têtu B; Caron D; Malenfant P; Cattaruzzi P; Audette M; Doillon C; Tremblay JP; Guérette B
Biochem Biophys Res Commun; 2002 May; 293(5):1544-9. PubMed ID: 12054692
[TBL] [Abstract][Full Text] [Related]
10. EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation.
Aoki T; Inoue S; Imamura H; Fukushima J; Takahashi S; Urano T; Hasegawa K; Ogushi T; Ouchi Y; Makuuchi M
Eur J Cancer; 2003 Jul; 39(11):1552-61. PubMed ID: 12855262
[TBL] [Abstract][Full Text] [Related]
11. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
[TBL] [Abstract][Full Text] [Related]
12. Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers.
Tsuneizumi M; Emi M; Nagai H; Harada H; Sakamoto G; Kasumi F; Inoue S; Kazui T; Nakamura Y
Clin Cancer Res; 2001 Nov; 7(11):3526-32. PubMed ID: 11705872
[TBL] [Abstract][Full Text] [Related]
13. Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer.
Liao Y; Grobholz R; Abel U; Trojan L; Michel MS; Angel P; Mayer D
Int J Cancer; 2003 Nov; 107(4):676-80. PubMed ID: 14520710
[TBL] [Abstract][Full Text] [Related]
14. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
[TBL] [Abstract][Full Text] [Related]
16. EBAG9 is a tumor-promoting and prognostic factor for bladder cancer.
Kumagai J; Urano T; Ogushi T; Takahashi S; Horie-Inoue K; Fujimura T; Azuma K; Muramatsu M; Ouchi Y; Kitamura T; Inoue S
Int J Cancer; 2009 Feb; 124(4):799-805. PubMed ID: 19030177
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.
Reimer TA; Anagnostopoulos I; Erdmann B; Lehmann I; Stein H; Daniel P; Dörken B; Rehm A
BMC Cancer; 2005 May; 5():47. PubMed ID: 15904507
[TBL] [Abstract][Full Text] [Related]
18. The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma.
Fukuda K; Tsujitani S; Maeta Y; Yamaguchi K; Ikeguchi M; Kaibara N
Gastric Cancer; 2002; 5(4):220-7. PubMed ID: 12491080
[TBL] [Abstract][Full Text] [Related]
19. Promoter analysis and chromosomal mapping of human EBAG9 gene.
Ikeda K; Sato M; Tsutsumi O; Tsuchiya F; Tsuneizumi M; Emi M; Imoto I; Inazawa J; Muramatsu M; Inoue S
Biochem Biophys Res Commun; 2000 Jul; 273(2):654-60. PubMed ID: 10873660
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]